Quick answer
Biomarin Pharmaceutical Inc (BMRN) reported revenue of $3.22B and net income of $348.9M for the fiscal year ended 2025-12-31, up 12.9% from $2.85B the year before, per its 10-K filed with the SEC on 2026-02-26.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $3.22B | $348.9M | — |
| 2024 (FY ending 2024-12-31) | $2.85B | $426.9M | — |
| 2023 (FY ending 2023-12-31) | $2.42B | $167.6M | — |
| 2022 (FY ending 2022-12-31) | $2.10B | $141.6M | — |
| 2021 (FY ending 2021-12-31) | $1.85B | -$64.1M | — |
| 2020 (FY ending 2020-12-31) | $1.86B | $854.0M | — |
| 2019 (FY ending 2019-12-31) | $1.70B | -$23.8M | — |
| 2018 (FY ending 2018-12-31) | $1.49B | -$77.2M | — |
| 2017 (FY ending 2017-12-31) | $1.31B | -$117.0M | — |
| 2016 (FY ending 2016-12-31) | $1.12B | -$630.2M | — |
Related
- BKR revenue, net income and debt history (Baker Hughes Company)
- BLK revenue, net income and debt history (BlackRock, Inc.)
- BMNR revenue, net income and debt history (Bitmine Immersion Technologies, Inc.)
- BMY revenue, net income and debt history (Bristol-Myers Squibb Company)
- BNY revenue, net income and debt history (Bank of New York Mellon Corp)
- BR revenue, net income and debt history (Broadridge Financial Solutions, Inc.)
- BRK-B revenue, net income and debt history (Berkshire Hathaway Inc)
- BRKR revenue, net income and debt history (Bruker Corporation)
Last updated 2026-10-16. Data only, not financial or tax advice.